Skip to main content

Day: March 6, 2023

Entrada Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results

– Established a transformative collaboration with Vertex to discover and develop intracellular Endosomal Escape Vehicle-therapeutics for myotonic dystrophy type 1 – – Actively working to resolve the clinical hold on its IND application for ENTR-601-44 – – Selected ENTR-601-45, expanding the Company’s commitment to include a potential therapy for people living with Duchenne who are amenable to exon 45 skipping – – Cash runway extended into 2H 2025 following the closing of the collaboration with Vertex – BOSTON, March 06, 2023 (GLOBE NEWSWIRE) — Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biopharmaceutical company aiming to transform the lives of patients by establishing intracellular Endosomal Escape Vehicle (EEV™) therapeutics as a new class of medicines, today reported financial...

Continue reading

Gas Turbine Market Size Worth USD 17.29 billion at a CAGR of 3.3% by 2028

Gas Turbine Market to Reach USD 17.29 Billion by 2028; Rising Electricity Consumption and Developing Aviation Industry to Bolster Market Growth: Fortune Business Insights™ Pune, India, March 06, 2023 (GLOBE NEWSWIRE) — The global gas turbine market size was USD 13.41 billion in 2021. The market is expected to grow from USD 13.80 billion in 2021 to USD 17.29 billion by 2028 at a CAGR of 3.3% in the 2021-2028 period. This information is provided by Fortune Business Insights, in its report titled, “Gas Turbine Market, 2021-2028.” The rising popularity regarding turbines’ benefits, increasing electricity consumption, and rapid developments in the aviation industry are likely to foster market growth.  Market Drivers & Restraints: The rising adoption of gas turbines instead of nuclear and coal turbines is likely to boost...

Continue reading

Science 37 Reports Fourth Quarter and Full Year 2022 Financial Results

RESEARCH TRIANGLE PARK, N.C., March 06, 2023 (GLOBE NEWSWIRE) — Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”), the industry-leading Metasite™, today reported its financial results for the quarter and full year ended December 31, 2022. “Fourth quarter results demonstrated a healthy rebound in bookings and continued efficiency and discipline with our cash resources,” stated David Coman, Chief Executive Officer of Science 37. “We remain confident that our strategy positions us well for profitable revenue growth and shareholder value creation ahead.” Quarterly Financial HighlightsRevenue was $15.9 million for the quarter ended December 31, 2022, a 22% decrease compared to the same period in 2021. Net bookings were $18.6 million for the quarter ended December 31, 2022, a 57.0% decrease compared to the same period...

Continue reading

Kineta to Host Key Opinion Leader Event on KVA12123: VISTA as an Immuno-Oncology Target

SEATTLE, March 06, 2023 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on developing next-generation immunotherapies to address cancer immune resistance, announced today it will host a virtual Key Opinion Leader (KOL) event on VISTA as an immuno-oncology target on Monday, March 20, 2023 at 10:00 AM ET. The event will feature immunology expert Michael A. Curran, PhD (MD Anderson Cancer Center Department of Immunology) who will discuss challenges in the current immuno-oncology landscape, along with the potential for VISTA blocking immunotherapy to address the problem of immunosuppression in the tumor microenvironment (TME), followed by a Fireside Chat with clinical oncology expert Patricia LoRusso, DO (Yale School of Medicine Cancer Center) on conducting clinical trials with novel immunotherapies...

Continue reading

Annexon Reports Fourth Quarter and Year-End 2022 Financial Results and Reiterates Anticipated Milestones

Initial Clinical Data from Phase 2 Trial of ANX007 in Patients with Geographic Atrophy On-track for Mid-2023 Oral Small Molecule ANX1502, for Autoimmune Indications, Advances into Multi-Ascending Dose Trial Well-capitalized with Operating Runway into 2025, Including through Multiple Mid-stage and Pivotal Clinical Trial Readouts Anticipated in 2023 and 2024 BRISBANE, Calif., March 06, 2023 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today outlined anticipated upcoming milestones across its portfolio of complement therapies and reported fourth quarter and full year 2022 financial results. “2022 was a year of focused execution at Annexon,...

Continue reading

TRX Gold Orders Additional Ball Mill for Buckreef Gold

Expanded Milling Capacity to Further Increase Gold ProductionFigure 1 1,000+ tpd Processing Plant at Buckreef Gold, showing new CIL tanks and conveyor feed to the new ball mills (Q1 2023)TORONTO, March 06, 2023 (GLOBE NEWSWIRE) — TRX Gold Corporation (TSX: TNX) (NYSE American: TRX) (the “Company” or “TRX Gold”) is pleased to announce that a 1,000 tonne per day (“tpd”) capacity ball mill has been ordered for the Company’s Buckreef Gold Project. As previously disclosed in the Company’s January 16th press release, TRX Gold is committed to a short-term objective of increasing Buckreef Gold’s current average annual throughput of oxide ore by 75-100%, through the addition of this new mill. Informational highlights:The 1,000 tpd mill has been ordered from CSI Energy Group (Tanzania) in partnership with Solo Resources Pty in South...

Continue reading

Wallbridge Continues to Expand Fenelon Gold System in Multiple Directions

Figure 1 Fenelon Gold. A) Fenelon Plan View and B) Plan View-WestFigure 2 Fenelon Gold. A) Fenelon- Plan View and B) Fenelon- Plan View- EastFigure 3 Fenelon Gold, Plan View, 825 metres Vertical DepthTORONTO, March 06, 2023 (GLOBE NEWSWIRE) — Wallbridge Mining Company Limited (TSX:WM, OTCQX:WLBMF) (“Wallbridge” or the “Company”) is pleased to report that new assay results from the 2022 exploration program at the Company’s 100%-owned Fenelon Gold project (“Fenelon”) have expanded the Area 51, Tabasco and Contact zones beyond the western and eastern limits of the 2023 Mineral Resource Estimate (“MRE”) footprint. These results underscore the potential to further increase the size of the deposit, which remains open in multiple directions. Attila Péntek, Wallbridge’s Vice President, Exploration, commented: “Wallbridge continues...

Continue reading

PureGold Provides Update on CCAA Proceedings; Announces Management Departures

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, March 06, 2023 (GLOBE NEWSWIRE) — Pure Gold Mining Inc. (NEX:PGM.H) (“PureGold” or the “Company”), announces today that it has filed a court application with the Supreme Court of British Columbia (the “Court”), to be heard on March 7, 2023, seeking to extend the stay of proceedings in the Company’s ongoing Companies’ Creditors Arrangement Act (“CCAA”) proceedings up to and including May 8, 2023, and approval of an Amended Interim Financing Term Sheet to provide for an increase to the authorized borrowings under the Interim Facility from US$10 million to US$15 million on substantially the same terms to the previously approved Interim Financing Term Sheet between a fund managed by Sprott Resource Lending...

Continue reading

With 51.1% CAGR, Network Slicing Market Size to Reach USD 13,662.9 Million by 2030

As per the report by Fortune Business Insights, the global Network Slicing Market Size is projected to reach USD 13,662.9 Million in 2030, at a CAGR of 51.1% during the forecast period, 2023-2030 Pune,India, March 06, 2023 (GLOBE NEWSWIRE) — The global Network Slicing Market Size was valued at USD 518.4 million in 2022. The market is projected to grow from USD 759.0 million in 2023 to USD 13,662.9 million by 2030, exhibiting a CAGR of 51.1% during the forecast period. Network slicing is a method of producing more than one logical and virtualized network over a combined multi-domain infrastructure. To support users, networks, services, and specific applications, mobile network operators can speedily create network slices with Network Function Virtualization (NFV), Software-Defined Networking (SDN), orchestration, analytics, and...

Continue reading

Password Management Market Size Expected to Reach USD 7.13 Billion, With 17.1% CAGR by 2030

As per the report by Fortune Business Insights, the global Password Management Market Size is projected to reach USD 7.12 billion in 2030, at a CAGR of 17.1% during the forecast period, 2023-2030 Pune,India, March 06, 2023 (GLOBE NEWSWIRE) — The global Password Management Market Size stood at USD 2.05 billion in 2022. The market is set to rise from USD 2.35 billion in 2023 to USD 7.13 billion by 2030, exhibiting a CAGR of 17.1% over the study period. The rise is due to the growing product adoption for business accounts, domain accounts, system accounts, and service accounts, among others. Fortune Business Insights™ provides this information in its research report, titled “Password Management Market Forecast, 2023-2030”. Key Industry Development- December 2022: Bitwarden incorporated password-less login authentication into...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.